Literature DB >> 22264049

Animal models for microbicide studies.

Ronald S Veazey1, Robin J Shattock, Per Johan Klasse, John P Moore.   

Abstract

There have been encouraging recent successes in the development of safe and effective topical microbicides to prevent vaginal or rectal HIV-1 transmission, based on the use of anti-retroviral drugs. However, much work remains to be accomplished before a microbicide becomes a standard element of prevention science strategies. Animal models should continue to play an important role in pre-clinical testing, with emphasis on safety, pharmacokinetic and efficacy testing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22264049      PMCID: PMC3712901          DOI: 10.2174/157016212799304715

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  77 in total

1.  Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide.

Authors:  Cecilia Cheng-Mayer; Yaoxing Huang; Agegnehu Gettie; Lily Tsai; Wuze Ren; Madina Shakirzyanova; Silvana T Sina; Nataliya Trunova; James Blanchard; Lisa M Miller Jenkins; Yungtai Lo; Marco L Schito; Ettore Appella
Journal:  AIDS       Date:  2011-09-24       Impact factor: 4.177

2.  Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.

Authors:  Dennis R Burton; Ann J Hessell; Brandon F Keele; Per Johan Klasse; Thomas A Ketas; Brian Moldt; D Cameron Dunlop; Pascal Poignard; Lara A Doyle; Lisa Cavacini; Ronald S Veazey; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

3.  High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques.

Authors:  Sundaram A Vishwanathan; Patricia C Guenthner; Carol Y Lin; Charles Dobard; Sunita Sharma; Debra R Adams; Ron A Otten; Walid Heneine; R Michael Hendry; Janet M McNicholl; Ellen N Kersh
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-01       Impact factor: 3.731

4.  Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques.

Authors:  Nicole Stolte-Leeb; Roberta Loddo; Sophia Antimisiaris; Tina Schultheiss; Ulrike Sauermann; Monika Franz; Spyridon Mourtas; Christophe Parsy; Richard Storer; Paolo La Colla; Christiane Stahl-Hennig
Journal:  AIDS Res Hum Retroviruses       Date:  2011-03-23       Impact factor: 2.205

Review 5.  Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection.

Authors:  Rikke Olesen; Angela Wahl; Paul W Denton; J Victor Garcia
Journal:  J Reprod Immunol       Date:  2011-01-21       Impact factor: 4.054

6.  Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer system.

Authors:  Alamelu Mahalingam; Julie I Jay; Kristofer Langheinrich; Shetha Shukair; Mike D McRaven; Lisa C Rohan; Betsy C Herold; Thomas J Hope; Patrick F Kiser
Journal:  Biomaterials       Date:  2011-08-27       Impact factor: 12.479

7.  One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates.

Authors:  Paul W Denton; Florence Othieno; Francisco Martinez-Torres; Wei Zou; John F Krisko; Elisa Fleming; Sima Zein; Daniel A Powell; Angela Wahl; Youn Tae Kwak; Brett D Welch; Michael S Kay; Deborah A Payne; Philippe Gallay; Ettore Appella; Jacob D Estes; Min Lu; J Victor Garcia
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

8.  Humanized Rag1-/- γc-/- mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes.

Authors:  Ramesh Akkina; Bradford K Berges; Brent E Palmer; Leila Remling; C Preston Neff; Jes Kuruvilla; Elizabeth Connick; Joy Folkvord; Kathy Gagliardi; Afework Kassu; Sarah R Akkina
Journal:  PLoS One       Date:  2011-06-14       Impact factor: 3.240

9.  A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice.

Authors:  C Preston Neff; Theresa Kurisu; Thomas Ndolo; Kami Fox; Ramesh Akkina
Journal:  PLoS One       Date:  2011-06-01       Impact factor: 3.240

Review 10.  The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment.

Authors:  Bradford K Berges; Mark R Rowan
Journal:  Retrovirology       Date:  2011-08-11       Impact factor: 4.602

View more
  30 in total

1.  Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.

Authors:  Dan H Barouch; Per Johan Klasse; Jason Dufour; Ronald S Veazey; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

2.  A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.

Authors:  Katherine Butler; Jana M Ritter; Shanon Ellis; Monica R Morris; Debra L Hanson; Janet M McNicholl; Ellen N Kersh
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-01       Impact factor: 3.731

Review 3.  New generation humanized mice for virus research: comparative aspects and future prospects.

Authors:  Ramesh Akkina
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

4.  Biology of mucosally transmitted sexual infection-translating the basic science into novel HIV intervention: a workshop summary.

Authors:  Damian Purcell; Anthony Cunningham; Stuart Turville; Gilda Tachedjian; Alan Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-10       Impact factor: 2.205

5.  Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220.

Authors:  Susan M Fetherston; Leslie Geer; Ronald S Veazey; Laurie Goldman; Diarmaid J Murphy; Thomas J Ketas; Per Johan Klasse; Sylvain Blois; Paolo La Colla; John P Moore; R Karl Malcolm
Journal:  J Antimicrob Chemother       Date:  2012-10-28       Impact factor: 5.790

Review 6.  Nonhuman primate models in AIDS research.

Authors:  David T Evans; Guido Silvestri
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

Review 7.  Comparison of the vaginal environment of Macaca mulatta and Macaca nemestrina throughout the menstrual cycle.

Authors:  Sarah V Hadzic; Xiaolei Wang; Jason Dufour; Lara Doyle; Preston A Marx; Andrew A Lackner; Daniel B Paulsen; Ronald S Veazey
Journal:  Am J Reprod Immunol       Date:  2014-02-13       Impact factor: 3.886

8.  Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.

Authors:  Alexandra Mumbauer; Agegenhu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

9.  Expression and localization of p-glycoprotein, multidrug resistance protein 4, and breast cancer resistance protein in the female lower genital tract of human and pigtailed macaque.

Authors:  Tian Zhou; Minlu Hu; Andrew Pearlman; Dorothy Patton; Lisa Rohan
Journal:  AIDS Res Hum Retroviruses       Date:  2014-06-12       Impact factor: 2.205

Review 10.  Rectal microbicide development.

Authors:  Ian McGowan; Charlene Dezzutti
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.